<SEC-DOCUMENT>0001104659-23-020772-index.html : 20230214
<SEC-HEADER>0001104659-23-020772.hdr.sgml : 20230214
<ACCEPTANCE-DATETIME>20230214081445
ACCESSION NUMBER:		0001104659-23-020772
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230214
DATE AS OF CHANGE:		20230214
GROUP MEMBERS:		CITADEL ADVISORS HOLDINGS LP
GROUP MEMBERS:		CITADEL GP LLC
GROUP MEMBERS:		CITADEL SECURITIES GP LLC
GROUP MEMBERS:		CITADEL SECURITIES GROUP LP
GROUP MEMBERS:		CITADEL SECURITIES LLC
GROUP MEMBERS:		KENNETH GRIFFIN

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RELMADA THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001553643
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				455401931
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88207
		FILM NUMBER:		23622720

	BUSINESS ADDRESS:	
		STREET 1:		2222 PONCE DE LEON BLVD. 3RD FLOOR
		CITY:			CORAL GABLES
		STATE:			FL
		ZIP:			33134
		BUSINESS PHONE:		646 876 3459

	MAIL ADDRESS:	
		STREET 1:		2222 PONCE DE LEON BLVD. 3RD FLOOR
		CITY:			CORAL GABLES
		STATE:			FL
		ZIP:			33134

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CAMP NINE, INC.
		DATE OF NAME CHANGE:	20120706

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITADEL ADVISORS LLC
		CENTRAL INDEX KEY:			0001423053
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		SOUTHEAST FINANCIAL CENTER
		STREET 2:		200 S. BISCAYNE BLVD., SUITE 3300
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33131
		BUSINESS PHONE:		305-929-6851

	MAIL ADDRESS:	
		STREET 1:		SOUTHEAST FINANCIAL CENTER
		STREET 2:		200 S. BISCAYNE BLVD., SUITE 3300
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33131
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>tm233474-29_sc13ga.htm
<DESCRIPTION>SC 13G/A
<TEXT>
Document 1 - file: tm233474-29_sc13ga.htm

</DOCUMENT>
</SEC-DOCUMENT>